CIK 0001840233 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Xilio Therapeutics, Inc.
Sign in to watch- Ticker
- XLO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851623397
- Phone
- 617-833-1027
- Business address
- 828 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-13 | GILEAD SCIENCES, INC. 10% owner | Purchase · Prefunded Warrants (right to buy) | +3,739,000 | $0.53 | $2.0M | 40,384,266 |
| 2025-11-26 | GILEAD SCIENCES, INC. 10% owner | Option exercise · Prefunded Warrants (right to buy) | +13,335,000 | $0.75 | $10.0M | 36,645,266 |
| 2025-11-26 | GILEAD SCIENCES, INC. 10% owner | Option exercise · Series B Warrants (right to buy) | −13,335,000 | 0 |
Page 1 of 1 · 3 trades